Inhibiting NF-κB activation can reduce the expression of anti-apoptotic genes including Bcl-x and Bcl-2, thereby inhibiting tumor cell proliferation, survival, and cancer progression by inducing apoptosis 26, 27. This evidence concerns the gene BCL2 and neoplasm.